Who owns Xbiotech?
- Ticker: XBIT
- CUSIP Number: 98400h102
Tip: Access positions for across all investors
Analyze quarterly positions in Xbiotech with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Xbiotech stock
Who bought or sold Xbiotech this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BlackRock | 1.3M | $5.1M | 4% | Dec 2024 |
|
| Vanguard Group | 1.1M | $4.2M | 0% | Dec 2024 |
|
| Geode Capital Management | 455k | $1.8M | 1% | Dec 2024 |
|
| Millennium Management | 264k | $1.0M | -6% | Dec 2024 |
|
| State Street Corporation | 230k | $907k | 2% | Dec 2024 |
|
| Northern Trust | 212k | $835k | 15% | Dec 2024 |
|
| Bridgeway Capital Management | 145k | $571k | -2% | Dec 2024 |
|
| American Century Companies | 124k | $491k | -5% | Dec 2024 |
|
| Morgan Stanley | 122k | $483k | -7% | Dec 2024 |
|
| Bank of New York Mellon | 91k | $360k | 7% | Dec 2024 |
|
| Dimensional Fund Advisors | 75k | $297k | 4% | Dec 2024 |
|
| Connor, Clark & Lunn Investment Management | 74k | $293k | -2% | Dec 2024 |
|
| Empowered Funds | 60k | $235k | -5% | Dec 2024 |
|
| Charles Schwab Investment Management | 58k | $231k | 0% | Dec 2024 |
|
| Goldman Sachs Group | 54k | $212k | 33% | Dec 2024 |
|
| UBS Group | 47k | $184k | 223% | Dec 2024 |
|
| National Bank Of Canada /fi/ | 33k | $255k | 0% | Sep 2024 |
|
| FMR | 33k | $128k | 12% | Dec 2024 |
|
| Deutsche Bank Aktiengesellschaft | 30k | $120k | 100% | Dec 2024 |
|
| Barclays | 30k | $119k | 14% | Dec 2024 |
|
| Nuveen Asset Management | 25k | $98k | 0% | Dec 2024 |
|
| Bank of America Corporation | 20k | $79k | 42% | Dec 2024 |
|
| Rhumbline Advisers | 20k | $78k | -7% | Dec 2024 |
|
| Bnp Paribas Arbitrage, Snc | 17k | $69k | -57% | Dec 2024 |
|
| Citigroup | 15k | $61k | 6% | Dec 2024 |
|
| Virtu Financial | 15k | $58k | 100% | Dec 2024 |
|
| Jpmorgan Chase & Co | 15k | $58k | 68% | Dec 2024 |
|
| TNB Financial | 13k | $53k | 0% | Dec 2024 |
|
| Citadel Advisors | 13k | $51k | 100% | Dec 2024 |
|
| Susquehanna International | 13k | $50k | 100% | Dec 2024 |
|
| Synovus Financial Corp. | 12k | $47k | 0% | Dec 2024 |
|
| Wells Fargo & Company | 12k | $46k | 28% | Dec 2024 |
|
| Mirae Asset Global Etfs Holdings | 10k | $79k | 100% | Sep 2024 |
|
| Corebridge Financial | 9.9k | $39k | 100% | Dec 2024 |
|
| Group One Trading | 7.5k | $30k | 100% | Dec 2024 |
|
| Royal Bank of Canada | 4.3k | $18k | 75% | Dec 2024 |
|
| Tower Research Capital | 4.2k | $17k | 202% | Dec 2024 |
|
| Summit Investment Advisors | 1.8k | $7.2k | 0% | Dec 2024 |
|
| New York State Common Retirement Fund | 1.6k | $6.0k | 0% | Dec 2024 |
|
| Legal & General Group | 1.6k | $6.3k | 0% | Dec 2024 |
|
| Jones Financial Companies, L.L | 1.6k | $6.2k | 100% | Dec 2024 |
|
| California State Teachers Retirement System | 1.5k | $5.9k | 0% | Dec 2024 |
|
| McIlrath & Eck | 753.00 | $3.0k | 0% | Dec 2024 |
|
| Sterling Capital Management | 677.00 | $2.7k | 1047% | Dec 2024 |
|
| Amalgamated Bank | 640.00 | $3.0k | 0% | Dec 2024 |
|
| GAMMA Investing | 151.00 | $595.997000 | 100% | Dec 2024 |
|
| Sachetta | 100.00 | $395.000000 | 0% | Dec 2024 |
|
| Us Bancorp | 100.00 | $395.000000 | 0% | Dec 2024 |
|
| NISA Investment Advisors | 88.00 | $347.996000 | 0% | Dec 2024 |
|
| CWM | 26.00 | $0 | -24% | Dec 2024 |
|
| IFP Advisors | 2.00 | $8.000000 | 100% | Dec 2024 |
|
| SBI Securities | 1.00 | $4.000000 | 100% | Dec 2024 |
|
Who sold out of Xbiotech?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Ubs Global Asset Management Americas | Sep 2024 | 254k | $2.0M |
| T. Rowe Price Associates | Sep 2024 | 24k | $183k |
| MetLife Investment Advisors | Sep 2024 | 12k | $94k |
| Jane Street | Sep 2024 | 11k | $86k |
| Simplex Trading | Sep 2024 | 159.00 | $999.998700 |
| Smartleaf Asset Management | Sep 2024 | 84.00 | $605.001600 |
| Capital Performance Advisors | Sep 2024 | 1.00 | $8.000000 |